ProPhase Labs Inc (OTCPK:PRPH)

Q4 2024 Prophase Labs Inc Earnings Call Transcript

Mar 31, 2025 / 03:00 PM GMT

Release Date Price: $4.04 (-8.11%)

Transcript 10-K8-K

Key Points

Positve

ProPhase Labs Inc (PRPH) has significantly reduced overhead by selling PMI and shutting down their lab, which is expected to improve financial efficiency.
The company has potential liquidity events, including the collection of $50 million from accounts receivable through Crown Medical Collections.
ProPhase Labs Inc (PRPH) is exploring the sale of Nebula Genomics, which could provide significant cash flow and alleviate financial pressure.
The company has developed a promising esophageal cancer test, BSmart, which has unique protein markers and potential for partnership with larger diagnostic companies.
ProPhase Labs Inc (PRPH) has streamlined operations and cut headcount, aiming to become a leaner and more efficient company focused on profitability.

Negative

ProPhase Labs Inc (PRPH) is currently facing financial constraints, with only $700k in the bank and reliance on potential loans or asset sales for liquidity.
The company has experienced a significant drop in stock price, trading below $1, which poses a risk of delisting from NASDAQ if not addressed within the given timeframe.
There is uncertainty regarding the timeline and success of collecting the $50 million in accounts receivable, which is crucial for financial stability.
ProPhase Labs Inc (PRPH) has faced challenges in executing its business plans over the past year, leading to financial losses and a need for restructuring.
The commercialization of the BSmart test and other products is still in early stages, with potential delays in securing necessary approvals and partnerships.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRPH.OQ - Prophase Labs Inc
Q4 2024 Prophase Labs Inc Earnings Call
Mar 31, 2025 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and good morning everyone. Welcome to today's presentation. My name is Noela Alexander Young, virtual event moderator here at Renmark Financial Communications. On behalf of our team, we want to thank everyone for joining us today for Prophase lab's 4th quarter and year-end 2024 results. Prophase is trading on the NASDAQ under the ticker symbol PRPH. Presenting today is Ted Carcass, Chairman and CEO. That being said, I will now hand the floor over to.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Ted. I am Carcass, CEO of Prophase Labs. I'm actually excited for this call. I got, I

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.